Gender related differences in treatment and response to statins in primary and secondary cardiovascular prevention: The never‐ending debate

@article{Cangemi2017GenderRD,
  title={Gender related differences in treatment and response to statins in primary and secondary cardiovascular prevention: The never‐ending debate},
  author={Roberto Cangemi and Giulio Francesco Romiti and Giuseppe Campolongo and Eleonora Ruscio and Susanna Sciomer and Daniele Gianfrilli and Valeria Raparelli},
  journal={Pharmacological Research},
  year={2017},
  volume={117},
  pages={148–155}
}

Tables from this paper

Sex disparities in the effect of statins on lipid parameters
TLDR
Statins appear to have a greater effect on increasing HDL-C levels in women than men while showing similar effect on other lipid parameters in both sexes, suggesting men should not be treated differently than women.
Statins are associated with a large reduction in all-cause mortality in women from a cardiac outpatient population
TLDR
The protective effect of primary prevention statins was stronger in women than men for both all-cause and cardiovascular mortality and statins seem to be effective regardless of treatment intensity, especially in women.
Sex-Related Differences in Pharmacokinetics and Pharmacodynamics of Frequently Prescribed Drugs: A Review of the Literature
TLDR
Considering sex-specific features in clinical trials and therapeutic guidelines is warranted to ensure efficacy and safety of medicines.
Diabetes and cardiovascular disease, are women protected or at higher risk?
TLDR
Data from a large cohort study examining the relationship between diabetes mellitus, CVD, and sex is reported, finding that while women without DM or CVD have lower CVD risk than men, women with DM have similar or higher risk of CVD events compared with men.
Are interventions to improve cardiovascular disease risk factors in premenopausal women effective? A systematic review and meta-analysis
TLDR
Results indicated that diet nor vitamin E/antioxidant did not significantly lower the CVD risk profiles, while lifestyle modification programme involving components of lifestyle education, counselling and multiple follow-ups showed great potential to improve risk profiles.
Sex Disparity In Secondary Prevention Pharmacotherapy And Clinical Outcomes Following Acute Coronary Syndrome.
TLDR
Lower adjusted long-term mortality amongst women suggests that as well as baseline differences between gender, optimization of secondary prevention medical therapy amongst women can lead to improved outcomes.
Sex-Differences in Discontinuation of Statin Treatment in Cancer Patients the Year before Death
TLDR
Neither the indication for statin treatment, i.e., primary prevention versus secondary prevention, nor age could explain the sex-difference in statin discontinuation, and there was no difference in cardiovascular events or mortality between men and women after statin discontinueduation.
Suboptimal lipid levels in clinical practice among Portuguese adults with dyslipidemia under lipid-lowering therapy: Data from the DISGEN-LIPID study.
  • P. M. da Silva, C. Aguiar, J. Morais
  • Medicine
    Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology
  • 2019
Gender-Related Determinants of Adherence to the Mediterranean Diet in Adults with Ischemic Heart Disease
TLDR
Male personality traits and perceived stress were associated with low Med-diet adherence regardless of the sex, age, and comorbidities, and gender-sensitive interventions should be explored to improve adherence in IHD.
Population-based cross-sectional study of 11 645 Spanish nonagenarians with type 2 diabetes mellitus: cardiovascular profile, cardiovascular preventive therapies, achievement goals and sex differences
TLDR
The study showed that the risk of cerebrovascular disease was similar in both male and female Spanish nonagenarians, indicating that the known sex differences in younger patients with T2DM persist in patients aged ≥90 years.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 84 REFERENCES
Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis.
TLDR
Statin therapy is an effective intervention in the secondary prevention of cardiovascular events in both sexes, but there is no benefit on stroke and all-cause mortality in women.
Gender differences in treatment of cardiovascular disease: a task force on gender of the ESC proposal on gender specific studies in cardiovascular pharmacology
TLDR
In this issue Lombardi et al. will discuss the gender-specific aspects of primary and secondary prevention showing how interventions effective in one sex may have different of lower effect in the other.
The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
TLDR
In patients without established cardiovascular disease but with cardiovascular risk factors, statin use was associated with significantly improved survival and large reductions in the risk of major cardiovascular events.
Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants.
TLDR
This literature-based meta-analysis did not find evidence for the benefit of statin therapy on all-cause mortality in a high-risk primary prevention set-up.
Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes.
TLDR
The term S&G is used for all medical relevant differences between women and men in the present review to include the inclusion of the gender dimension into biomedical research since ‘it helps improve the scientific quality …’.
...
1
2
3
4
5
...